|
Sep 21
|
Aligos Therapeutics Announces IND Clearance for NASH lead, ALG-055009
|
|
Jul 19
|
Aligos Therapeutics Announces the Selection of Stephen Harrison, MD as Principal Investigator of Ph2a Study and Key Study Design Elements/Milestones for NASH Drug Candidate, ALG-055009
|
|
May 24
|
Aligos Therapeutics to Present at the Jefferies 2023 Healthcare Conference
|